Genetic Technologies (GENE -0.9%) slips this morning after the company names its COO and acting Chief Executive Alison Mew as its permanent CEO, less than two weeks after its former head, Paul MacLeman - along with several other company executives - resigned. Last month Mr. MacLeman stepped down in protest after GENE's founder, Mervyn Jacobson, used his 29% stake in the company to block the re-election of Chairman Mel Bridges.
Genetic Technologies (GENE -0.9%) slips this morning after the company names its COO and acting...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs